Press Release: Dialogue Acquires Koble's Assets to Strengthen Women's Health Offering
Dialogue acquires Koble's assets to strengthen women's health offering Canada NewsWire MONTREAL, March 26, 2024 Canada's premier virtual healthcare and wellness platform enhances existing women's h
Sun Life Completes Previously Announced Acquisition of Dialogue
Dialogue Announces Voting Results From Special Meeting of Shareholders
Dialogue Announces Filing of Management Proxy Circular for the Special Meeting of Shareholders to Approve the Arrangement With Sun Life
Dialogue Health Technologies Reports Second Quarter 2023 Results
Dialogue to Release Financial Results for the Second Quarter of 2023 on August 14, 2023
Express News | Dialogue Health Technologies Inc Price Target Raised to C$5.15/Share From C$4.00 by CIBC World Markets
Express News | Dialogue Health Technologies Inc. Price Target Raised to C$5.15/Share From C$4.00 by TD Securities
Dialogue Health Technologies Inc. Cut to Tender From Hold by TD Securities
Dialogue Health Technologies Inc. Cut to Tender From Hold by TD Securities
Express News | Dialogue Health and Sun Life Brief: Dialogue to Be Acquired by Sun Life; Comes After Dialogue Entered Into License Agreement With Sun Life U.S.
Dialogue to Be Acquired by Sun Life
Canadian Investment Regulatory Organization Trading Halt - CARE
Dialogue Enters Into License Agreement With Sun Life U.S.
Express News | Dialogue Health Technologies Inc. Price Target Raised to C$4.00/Share From C$3.25 by TD Securities
Express News | Dialogue Health Technologies Inc Price Target Raised to C$4.00/Share From C$3.50 by CIBC World Markets
Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 58% Above Its Share Price
Express News | Dialogue Health Technologies Inc. Price Target Is Maintained at C$6.25/Share by National Bank
Dialogue Health Technologies Inc. Price Target Cut to C$6.25/Share From C$6.75 by National Bank
Dialogue Health Technologies Inc. Price Target Cut to C$6.25/Share From C$6.75 by National Bank
Express News | Dialogue Health Technologies Inc Is Maintained at Neutral by CIBC World Markets
Express News | Dialogue Health Technologies Inc. Price Target Cut to C$5.00/Share From C$6.00 by RBC Capital